SHINYA YAMAMOTO to Antiviral Agents
This is a "connection" page, showing publications SHINYA YAMAMOTO has written about Antiviral Agents.
Connection Strength
0.900
-
Retreatment or prolonged antiviral therapy in severe acute respiratory syndrome Coronavirus-2 infection among immunocompromised patients during 2022-2023: A nationwide claims-based cohort study in Japan. J Infect Chemother. 2025 Nov; 31(11):102830.
Score: 0.618
-
Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate. Lancet Infect Dis. 2023 04; 23(4):402-403.
Score: 0.128
-
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2. Nature. 2022 07; 607(7917):119-127.
Score: 0.122
-
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1. Lancet Infect Dis. 2023 05; 23(5):525-526.
Score: 0.032